University of East Anglia Featured PhD Programmes
King’s College London Featured PhD Programmes
University of Nottingham Featured PhD Programmes
"leukaemia"×
10 miles

leukaemia PhD Projects, Programs & Scholarships

We have 22 leukaemia PhD Projects, Programs & Scholarships

  • "leukaemia" ×
  • clear all
Order by 
Showing 1 to 15 of 22
  Proteomic and mass spectrometric analysis of disease progression in Acute Myeloid Leukaemia
  Prof A D Whetton, Dr Andrew Pierce
Applications accepted all year round

Funding Type

PhD Type

Acute myeloid leukaemia is a disease where unfortunately outcomes have improved little in the recent past and new approaches are required in treatment of the disease.
  Normal and Leukaemic Blood Stem/Progenitor Cell Biology
  Prof P Vyas, Prof A Mead
Application Deadline: 24 July 2020

Funding Type

PhD Type

Our laboratory studies the mechanisms regulating normal blood stem and progenitor cell differentiation and how these are perturbed in blood cancers such as Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndromes (MDS).
  Normal and Leukaemic Blood Stem/Progenitor Cell Biology
  Prof P Vyas, Prof A Mead
Application Deadline: 24 July 2020

Funding Type

PhD Type

Our laboratory studies the mechanisms regulating normal blood stem and progenitor cell differentiation and how these are perturbed in blood cancers such as Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndromes (MDS).
  VC International Scholarship in Cancer & Genetics - Developing targeted drugs to treat acute myeloid leukaemia
  Prof R Darley, Dr A Tonks, Prof A Brancale, Dr S Knapper
Application Deadline: 1 June 2020

Funding Type

PhD Type

AML is estimated to affect over 1 million individuals annually worldwide. Standard treatment based on chemotherapy fails for the majority of patients.
  Targeting IDH mutations in acute myeloid leukaemia
  Dr L. Kats
Applications accepted all year round

Funding Type

PhD Type

Acute Myeloid Leukaemia (AML) is an aggressive disease with poor prognosis and development of novel treatment options is urgently needed.
  The spleen as a site of relapse for early T-cell progenitor leukaemia
  Dr T Chonghaile, Prof J Prehn
Applications accepted all year round

Funding Type

PhD Type

Early T-cell progenitor ALL (ETP-ALL) originates from a block at early stages of T-cell development, has a poor prognosis with risk for relapse.
  Investigating the role of LC3 associated phagocytosis in regulating leukaemia progression in the tumour microenvironment (Rushworth U20MEDSF)
  Dr S Rushworth, Dr P Powell
Application Deadline: 31 May 2020

Funding Type

PhD Type

Our laboratory studies the mechanisms regulating normal blood stem cells and cancers such as Acute Myeloid Leukaemia (AML) and how they interact with the bone marrow microenvironment.
  Epigenetics and Cancer: Development of Novel Tools to Determine how Aberrant V(D)J Recombination Reactions Cause Leukaemia
  Research Group: School of Molecular and Cellular Biology
  Dr J Boyes
Applications accepted all year round

Funding Type

PhD Type

V(D)J recombination generates a highly diverse set of immunoglobulin and T cell receptor genes to enable vertebrates to fight a vast range of infections.
  Single Cell Genomics
  Prof A Mead
Application Deadline: 24 July 2020

Funding Type

PhD Type

The Haematopoietic Stem Cell Biology (HSCB) Laboratory is focused on understanding how the normal haematopoietic stem/progenitor hierarchy is disrupted during the development of myeloid malignancies.
  Single Cell Genomics
  Prof A Mead
Application Deadline: 24 July 2020

Funding Type

PhD Type

The Haematopoietic Stem Cell Biology (HSCB) Laboratory is focused on understanding how the normal haematopoietic stem/progenitor hierarchy is disrupted during the development of myeloid malignancies.
  Structure based design of novel warheads for use in peptide-drug conjugates
  Dr S Butterworth, Dr A Tirella, Dr D Wiseman
Applications accepted all year round

Funding Type

PhD Type

Chronic Myelomonocytic Leukaemia (CMML) is an orphan disease defined by myeloid dysplasia, myeloproliferation and a malignant expansion of classical monocytes.
  Epigenetics and Cancer: Determining how Mistakes in V(D)J Recombination Trigger Leukaemias and Lymphomas
  Research Group: School of Molecular and Cellular Biology
  Dr J Boyes
Application Deadline: 1 June 2020

Funding Type

PhD Type

V(D)J recombination is essential to produce an effective adaptive immune system but since the reaction involves the breakage and rejoining of DNA, it is highly dangerous and errors have long been thought to lead to leukaemias and lymphomas.
  Oncogenic reprogramming of immune cells, a novel mechanism of drug-resistance.
  Dr P Laslo
Applications accepted all year round

Funding Type

PhD Type

Under pathogenic challenges, cells of the innate system become epigenetically reprogrammed and establish immune memory.
  Normal and malignant blood stem cell biology
  Dr D G Kent, Prof I Hitchcock
Application Deadline: 30 June 2020

Funding Type

PhD Type

One of the simplest and most provocative concepts in all of stem cell biology is how a single stem cell can give rise to any of the highly specialised cell types of a given tissue while also having the capacity to make a new equally potent stem cell.
  Developing new antibody-based therapeutics for neuroblastoma
  Prof A Sala
Applications accepted all year round

Funding Type

PhD Type

Metastatic neuroblastoma is a cancer of the nervous system that kills the majority of the affected children. Although there have been tremendous advances in the understanding of the molecular causes of the disease, patients are still treated with highly toxic mixtures of chemicals and radiation.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2020
All rights reserved.